...
首页> 外文期刊>BMC Cardiovascular Disorders >Long-term outcomes of conservative treatment and endovascular treatment in patients with symptomatic spontaneous isolated superior mesenteric artery dissection: a single-center experience
【24h】

Long-term outcomes of conservative treatment and endovascular treatment in patients with symptomatic spontaneous isolated superior mesenteric artery dissection: a single-center experience

机译:患有症状自发隔离患者的保守治疗和血管内治疗的长期结果,优质肠系膜动脉解剖:单中心经验

获取原文
           

摘要

Spontaneous isolated superior mesenteric artery dissection (SISMAD) is a rare vascular disorder, and the treatment strategies remain controversial. This study aimed to compare outcomes of conservative and endovascular treatments in symptomatic patients with SISMAD. Forty-two consecutive SISMAD patients who were admitted to a single center between October 2009 and May 2018 were enrolled in this study. Based on their symptoms, 15 had conservative treatment, and 27 had endovascular treatment. The baseline characteristics, treatments, and follow-up results of the conservative group and endovascular group were analysed. The rates of symptom relief were 93.3% in the conservative group and 96.3% in the endovascular group. The procedure-related complications in the endovascular group included one case of pseudoaneurysm formation in the left brachial artery. During the follow-up period (median 28.5?months), a higher proportion of patients in the conservative group had symptom recurrence (42.9% in the conservative group versus 4.8% in the endovascular group, p??0.001). Four patients in the conservative group and one patient in the endovascular group had additional endovascular intervention during follow-up. Compared with the conservative group, patients in the endovascular group had statistically significantly longer symptom-free survival (p?=?0.014) and a higher rate of superior mesenteric artery (SMA) remodeling (p??0.001). For symptomatic SISMAD, endovascularly treated patients had a lower rate of symptom recurrence and a higher rate of SMA remodeling in the long term. Prospective, multi-center studies are needed to confirm the long-term outcomes of both treatments.
机译:自发的孤立的优质肠系膜动脉解剖(Sismad)是一种罕见的血管障碍,治疗策略仍然存在争议。本研究旨在比较症状患者的保守和血管内治疗的结果。在2009年10月和2018年5月在本研究中注册了四十两名连续的Sismad患者,达到单一中心。根据症状,15种保守治疗,27例血管内治疗。分析了保守群和血管内血管基的基线特征,治疗和后续结果。症状缓解率在保守基团中为93.3%,血管内群体中的96.3%。血管血管组中的程序相关的并发症包括左臂动脉中伪肿瘤形成的一种情况。在随访期间(中位数28.5?月份),保守基团中患者比例较高,症状复发(42.9%在保守群中,血管内群中的4.8%,P?<0.001)。保守群体中的四名患者和血管内血管基的一名患者在随访期间在额外的血管内干预。与保守群体相比,血管内血管基团的患者在统计学上显着更长的症状存活率(P?= 0.014)和更高的优质肠系膜动脉(SMA)重塑率(P?<0.001)。对于症状Sismad,期间血管内治疗的患者在长期内具有较低的症状复发率和更高的SMA重塑率。需要前瞻性的多中心研究来确认这两种治疗的长期结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号